DSIJ Mindshare

Life Insurance Corporation of India Holds 4.32 Per Cent Stake: Leading Pharma company Commissions New Rs 205 Crore Manufacturing Facility At Pithampur

In the last 12 months, the stock is down by 8.99 per cent while from its 52-week low it is up by 20.7 per cent.

DSIJ Intelligence-2 0 305 Article rating: 3.6

In the last 12 months, the stock is down by 8.99 per cent while from its 52-week low it is up by 20.7 per cent.

This pharma company trades higher after receiving final approval from US FDA for its new drug application

Shares of the company zoomed 8 per cent on getting the final nod for Ketorolac Tromethamine Injection.

DSIJ Intelligence 0 18877 Article rating: 4.1

Shares of the company zoomed 8 per cent on getting the final nod for Ketorolac Tromethamine Injection. 

RSS
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR